TTN Gene Cardiomyopathy dilated type 1G Genetic Test
Test Name: TTN Gene Cardiomyopathy dilated type 1G Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Cardiovascular Pneumology Disorders
Doctor: Cardiologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for TTN Gene Cardiomyopathy, dilated type 1G NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TTN Gene Cardiomyopathy, dilated type 1G NGS Genetic DNA Test gene TTN
Test Details:
TTN gene cardiomyopathy, dilated type 1G NGS genetic test is a type of genetic test that is used to detect mutations in the TTN gene associated with dilated cardiomyopathy (DCM) type 1G. Dilated cardiomyopathy is a condition characterized by the enlargement and weakening of the heart muscle, leading to reduced pumping ability and potential heart failure. It is a genetically heterogeneous disorder, meaning that mutations in multiple genes can cause the condition. However, mutations in the TTN gene are the most common cause of familial DCM.
The TTN gene provides instructions for producing a protein called titin, which is responsible for the structural integrity of cardiac muscle cells. Mutations in the TTN gene can disrupt the normal function of titin, leading to the development of DCM.
The NGS (Next-Generation Sequencing) genetic test is a high-throughput DNA sequencing technology that can rapidly and accurately analyze multiple genes simultaneously. In the case of TTN gene cardiomyopathy, dilated type 1G NGS genetic test, it specifically focuses on sequencing the TTN gene to identify any mutations or variations that may be present.
This genetic test can help in the diagnosis of individuals suspected to have TTN gene-related dilated cardiomyopathy. It can also be used for carrier testing and prenatal testing in families with a known TTN gene mutation. The results of the genetic test can provide valuable information for genetic counseling, treatment planning, and management of individuals with TTN gene cardiomyopathy. It can also aid in the identification of at-risk family members who may benefit from regular cardiac screening and early intervention.
It is important to note that genetic testing for TTN gene cardiomyopathy should be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate guidance and support based on the test results.
| Test Name | TTN Gene Cardiomyopathy dilated type 1G Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for TTN Gene Cardiomyopathy, dilated type 1G NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TTN Gene Cardiomyopathy, dilated type 1G NGS Genetic DNA Test gene TTN |
| Test Details | TTN gene cardiomyopathy, dilated type 1G NGS genetic test is a type of genetic test that is used to detect mutations in the TTN gene associated with dilated cardiomyopathy (DCM) type 1G. Dilated cardiomyopathy is a condition characterized by the enlargement and weakening of the heart muscle, leading to reduced pumping ability and potential heart failure. It is a genetically heterogeneous disorder, meaning that mutations in multiple genes can cause the condition. However, mutations in the TTN gene are the most common cause of familial DCM. The TTN gene provides instructions for producing a protein called titin, which is responsible for the structural integrity of cardiac muscle cells. Mutations in the TTN gene can disrupt the normal function of titin, leading to the development of DCM. The NGS (Next-Generation Sequencing) genetic test is a high-throughput DNA sequencing technology that can rapidly and accurately analyze multiple genes simultaneously. In the case of TTN gene cardiomyopathy, dilated type 1G NGS genetic test, it specifically focuses on sequencing the TTN gene to identify any mutations or variations that may be present. This genetic test can help in the diagnosis of individuals suspected to have TTN gene-related dilated cardiomyopathy. It can also be used for carrier testing and prenatal testing in families with a known TTN gene mutation. The results of the genetic test can provide valuable information for genetic counseling, treatment planning, and management of individuals with TTN gene cardiomyopathy. It can also aid in the identification of at-risk family members who may benefit from regular cardiac screening and early intervention. It is important to note that genetic testing for TTN gene cardiomyopathy should be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate guidance and support based on the test results. |
